PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Cambridge Healthtech Institute

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

New Technologies for Biologics Delivery - Conference at CHI’s Biologics Formulation Summit - Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies - CHICorporate.com / HealthTech.com
New Technologies for Biologics Delivery - Conference at CHI’s Biologics Formulation Summit

 

NewswireToday - /newswire/ - Needham, MA, United States, 2014/02/20 - Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies - CHICorporate.com / HealthTech.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The drug delivery field is emerging as a key sector in driving innovation to bring new therapies to market and increase profitability. On May 6-7, 2014 at the Seaport World Trade Center in Boston, MA, Cambridge Healthtech Institute (CHI) will hold its Inaugural New Technologies for Biologics Delivery and Targeting conference.

This conference will cover novel delivery approaches and their roles in developing and delivering biologics, designing targeted delivery approaches and improving efficacy and safety. These strategies are directed to the development of patient-centric therapies. The keynote speaker will be Omid Farokhzad, M.D., Associate Professor, Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital and Harvard Medical School. Dr. Farokhzad will discuss targeted polymeric nanoparticles: from discovery to clinical trials.

Polymeric nanoparticles can deliver drugs in the optimum dosage over time, thus increasing the efficacy of the drug, maximizing patient compliance and enhancing the ability to use highly toxic, poorly soluble, or relatively unstable drugs. The successful clinical translation of therapeutic nanoparticles requires optimization of many distinct parameters resulting in a large number of potential variables for optimization which is impractical to achieve using a low-throughput approach. The goal of Dr. Farokhzad’s talk is to review his lab’s efforts in the design and optimization of polymeric nanoparticles for medical applications, which formed the foundation for the clinical translation of the first-in-human targeted and controlled-release nanoparticles, BIND-014 and SEL-068.

Additional speakers include:

- Mansoor M. Amiji, Ph.D., Northeastern University
- Ajay K. Banga, Ph.D., Mercer University
- Scott Banta, Ph.D., Columbia University
- Ashutosh Chilkoti, Ph.D., Duke University
- Donald Cropek, Ph.D., U.S. Army Corps of Engineers
- Ramin Darvari, Ph.D., Pfizer, Inc.
- Drew Elias, Ph.D., Johnson & Johnson
- Per-Ola Freskgard, Ph.D., Roche
- Marian Gindy, Ph.D., Merck Research Laboratories
- Pankaj Karande, Ph.D., Rensselaer Polytechnic Institute
- Andrea Leone-Bay, Ph.D., MannKind Corp.
- Ashim K. Mitra, Ph.D., University of Missouri-Kansas City
- Hayat Onyuksel, Ph.D., University of Illinois
- Dushyant Varshney, Ph. D., Novartis

This conference is Part 2 at CHI’s Inaugural Biologics Formulation & Delivery Summit (May 5-7).

Writers and editors are invited to attend. To request a press pass or arrange an interview with a speaker, email Lisa Scimemi: lscimemi[.]healthtech.com

Advance registration discounts and student fellowships will be offered until March 14, 2014.

About Cambridge Healthtech Institute (CHI)
Cambridge Healthtech Institute (chicorporate.com), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Cambridge Healthtech Institute

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


New Technologies for Biologics Delivery - Conference at CHI’s Biologics Formulation Summit

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: James Prudhomme - HealthTech.com 
781-972-5400 jprudhomme[.]healthtech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cambridge Healthtech Institute securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Cambridge Healthtech Institute / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)